
<head>
<style>
.card {
  /* Add shadows to create the "card" effect */
  box-shadow: 0 4px 8px 0 rgba(0,0,0,0.2);
  transition: 0.3s;
  padding-left: 20px;
  padding-right: 20px;
  padding-top: 10px;
  padding-bottom: 10px;

}

.card-query {
    background: #EEEEFF;
    box-shadow: 0 0px 8px 0 rgba(0,0,0,0.2);
}

.button {
  background-color: #EEEEEE;
  border: none;
  color: black;
  padding: 15px 32px;
  text-align: center;
  text-decoration: none;
  display: inline-block;
  font-size: 16px;
}

</style>
</head>
<body style="margin-left: 10%; margin-right: 10%; padding-top: 70px;">
<div class="card card-query"><h2>Query: One Health surveillance of humans and potential sources of future spillover or ongoing exposure for transmission hosts</h2><br /></div><br /><br /><br /><div class="card"><h3>Quantifying transmission of emerging zoonoses: 3 Using mathematical models to maximize the value of surveillance data 4 5 6 7</h3>
<p style="text-align: justify; text-justify: inter-word;">Estimating epidemiological measures is a challenging task in any pathogen system, and 82 the unique properties of zoonotic diseases can exacerbate these difficulties. Infectious disease 83 surveillance often records temporal information and certain aspects of spatial information about 84 human cases, but the underlying transmission events are seldom observed. In a zoonotic system, 85 this means that an observed human infection could have been caused by a previous human case 86 or by zoonotic spillover. Without intensive contact tracing, or sequence data in the case of fast-87 evolving pathogens, quantifying the relative contribution of zoonotic versus human-to-human 88 . CC-BY 4.0 International license is made available under a The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. It . https://doi.org/10.1101/677021 doi: bioRxiv preprint 5 transmission is a major challenge; identifying the source of infection for specific individuals is 89 an even bigger one. 90</p>
<p align="right"><i>score: 48</i></p>

</div><br /><br /><br /><div class="card"><h3>(no title)</h3>
<p style="text-align: justify; text-justify: inter-word;">A novel bat-origin coronavirus emerged in Wuhan, China in December 2019 and continues to spread across China and the world. At the time of writing, a massive global response has been implemented to control the disease as it spreads from person to person. Yet the high-risk human-wildlife interactions and interfaces that led to the emergence of SARS-CoV and of 2019-nCoV continue to exist in emerging disease hotspots globally. To prevent the next epidemic and pandemic related to these interfaces, we call for research and investment in three areas: 1) surveillance among wildlife to identify the high-risk pathogens they carry; 2) surveillance among people who have contact with wildlife to identify early spillover events; and 3) improvement of market biosecurity regarding the wildlife trade. As the emergence of a novel virus anywhere can impact the furthest reaches of our connected world, international collaboration among scientists is essential to address these risks and prevent the next pandemic.</p>
<p align="right"><i>score: 48</i></p>

</div><br /><br /><br /><div class="card"><h3>Clinical Medicine Intense Surveillance Is Vital for Preventing Sustained Transmission in New Locations</h3>
<p style="text-align: justify; text-justify: inter-word;">The outbreak of pneumonia originating in Wuhan, China, has generated 24,500 confirmed cases, including 492 deaths, as of 5 February 2020. The virus (2019-nCoV) has spread elsewhere in China and to 24 countries, including South Korea, Thailand, Japan and USA. Fortunately, there has only been limited human-to-human transmission outside of China. Here, we assess the risk of sustained transmission whenever the coronavirus arrives in other countries. Data describing the times from symptom onset to hospitalisation for 47 patients infected early in the current outbreak are used to generate an estimate for the probability that an imported case is followed by sustained human-to-human transmission. Under the assumptions that the imported case is representative of the patients in China, and that the 2019-nCoV is similarly transmissible to the SARS coronavirus, the probability that an imported case is followed by sustained human-to-human transmission is 0.41 (credible interval [0.27, 0.55]). However, if the mean time from symptom onset to hospitalisation can be halved by intense surveillance, then the probability that an imported case leads to sustained transmission is only 0.012 (credible interval [0, 0.099]). This emphasises the importance of current surveillance efforts in countries around the world, to ensure that the ongoing outbreak will not become a global pandemic.</p>
<p align="right"><i>score: 45</i></p>

</div><br /><br /><br /><div class="card"><h3>Characterizing the Transmission Dynamics and Control of Ebola Virus Disease</h3>
<p style="text-align: justify; text-justify: inter-word;">Carefully calibrated transmission models have the potential to guide public health officials on the nature and scale of the interventions required to control epidemics. In the context of the ongoing Ebola virus disease (EVD) epidemic in Liberia, Drake and colleagues, in this issue of PLOS Biology, employed an elegant modeling approach to capture the distributions of the number of secondary cases that arise in the community and health care settings in the context of changing population behaviors and increasing hospital capacity. Their findings underscore the role of increasing the rate of safe burials and the fractions of infectious individuals who seek hospitalization together with hospital capacity to achieve epidemic control. However, further modeling efforts of EVD transmission and control in West Africa should utilize the spatial-temporal patterns of spread in the region by incorporating spatial heterogeneity in the transmission process. Detailed datasets are urgently needed to characterize temporal changes in population behaviors, contact networks at different spatial scales, population mobility patterns, adherence to infection control measures in hospital settings, and hospitalization and reporting rates.</p>
<p align="right"><i>score: 44</i></p>

</div><br /><br /><br /><div class="card"><h3>Rapid Detection of Novel Coronavirus (COVID-19) by Reverse Transcription- Loop-Mediated Isothermal Amplification</h3>
<p style="text-align: justify; text-justify: inter-word;">This test was performed in under 30 minutes. This approach could be used for monitoring of exposed individuals or potentially aid with screening efforts in the field and potential ports of entry.</p>
<p align="right"><i>score: 42</i></p>

</div><br /><br /><br /><div class="card"><h3>Estimates of Outbreak Risk from New Introductions of Ebola with Immediate and Delayed Transmission Control Affairs Salt Lake City Health Care System, Salt Lake City</h3>
<p style="text-align: justify; text-justify: inter-word;">While the ongoing Ebola outbreak continues in the West Africa countries of Guinea, Sierra Leone, and Liberia, health officials elsewhere prepare for new introductions of Ebola from infected evacuees or travelers. We analyzed transmission data from patients (i.e., evacuees, international travelers, and those with locally acquired illness) in countries other than the 3 with continuing Ebola epidemics and quantitatively assessed the outbreak risk from new introductions by using different assumptions for transmission control (i.e., immediate and delayed). Results showed that, even in countries that can quickly limit expected number of transmissions per case to <1, the probability that a single introduction will lead to a substantial number of transmissions is not negligible, particularly if transmission variability is high. Identifying incoming infected travelers before symptom onset can decrease worst-case outbreak sizes more than reducing transmissions from patients with locally acquired cases, but performing both actions can have a synergistic effect.</p>
<p align="right"><i>score: 39</i></p>

</div><br /><br /><br /><div class="card"><h3>Genetic Evidence of Middle East Respiratory Syndrome Coronavirus (MERS-Cov) and Widespread Seroprevalence among Camels in Kenya</h3>
<p style="text-align: justify; text-justify: inter-word;">We describe the first genome isolation of Middle East respiratory syndrome coronavirus (MERS-CoV) in Kenya. This fatal zoonotic pathogen was first described in the Kingdom of Saudi Arabia in 2012. Epidemiological and molecular evidence revealed zoonotic transmission from camels to humans and between humans. Currently, MERS-CoV is classified by the WHO as having high pandemic potential requiring greater surveillance. Previous studies of MERS-CoV in Kenya mainly focused on site-specific and archived camel and human serum samples for antibodies. We conducted active nationwide cross-sectional surveillance of camels and humans in Kenya, targeting both nasal swabs and plasma samples from 1,163 camels and 486 humans collected from January 2016 to June 2018. A total of 792 camel plasma samples were positive by ELISA. Seroprevalence increased with age, and the highest prevalence was observed in adult camels (82.37%, 95% confidence interval (CI) 79.50-84.91). More female camels were significantly seropositive (74.28%, 95% CI 71.14-77.19) than male camels (P \ 0.001) (53.74%, 95% CI 48.48-58.90). Only 11 camel nasal swabs were positive for MERS-CoV by reverse transcription-quantitative PCR. Phylogenetic analysis of whole genome sequences showed that Kenyan MERS-CoV clustered within sub-clade C2, which is associated with the African clade, but did not contain signature deletions of orf4b in African viruses. None of the human plasma screened contained neutralizing antibodies against MERS-CoV. This study confirms the geographically widespread occurrence of MERS-CoV in Kenyan camels. Further one-health surveillance approaches in camels, wildlife, and human populations are needed.</p>
<p align="right"><i>score: 39</i></p>

</div><br /><br /><br /><div class="card"><h3>Modeling the Comparative Impact of Individual Quarantine vs. Active Monitoring of Contacts for the Mitigation of COVID-19</h3>
<p style="text-align: justify; text-justify: inter-word;">Individual quarantine and active monitoring of contacts are core disease control strategies, particularly for emerging infectious diseases such as Coronavirus Disease 2019 . To estimate the comparative efficacy of these interventions to control COVID-19, we fit a stochastic branching model, comparing two sets of reported parameters for the dynamics of the disease. Our results suggest that individual quarantine may contain an outbreak of COVID-19 with a short serial interval (4.8 days) only in settings with high intervention performance where at least three-quarters of infected contacts are individually quarantined. However, in settings where this performance is unrealistically high and the outbreak of COVID-19 continues to grow, so too will the burden of the number of contacts traced for active monitoring or quarantine. In such circumstances where resources are prioritized for scalable interventions such as social distancing, we show active monitoring or individual quarantine of high-risk contacts can contribute synergistically to social distancing. To the extent that interventions based on contact tracing can be implemented, therefore, they can help mitigate the spread of COVID-19. Our model highlights the urgent need for more data on the serial interval and the extent of presymptomatic transmission in order to make data-driven policy decisions regarding the cost-benefit comparisons of individual quarantine vs. active monitoring of contacts.</p>
<p align="right"><i>score: 39</i></p>

</div><br /><br /><br /><div class="card"><h3>Quantifying bias of COVID-19 prevalence and severity estimates in Wuhan, China that depend on reported cases in international travelers</h3>
<p style="text-align: justify; text-justify: inter-word;">We estimate that the global ability to detect imported cases is 38% (95% HPDI 22% -64%) of Singapore's capacity. Equivalently, an estimate of 2.8 (95% HPDI 1.5 -4.4) times the current number of imported cases, could have been detected, if all countries had had the same detection capacity as Singapore. Using the second component of the Global Health Security index to stratify likely case-detection capacities, we found that the ability to detect imported cases relative to Singapore among high surveillance locations is 40% (95% HPDI 22% -67%), among intermediate surveillance locations it is 37% (95% HPDI 18% -68%), and among low surveillance locations it is 11% (95% HPDI 0% -42%). Using a simple mathematical model, we further find that treating all travelers as if they were residents (rather than accounting for the brief stay of some of these travelers in Wuhan) can modestly contribute to underestimation of prevalence as well. We conclude that estimates of case counts in Wuhan based on assumptions of perfect detection in travelers . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. : medRxiv preprint</p>
<p align="right"><i>score: 38</i></p>

</div><br /><br /><br /><div class="card"><h3>A New Approach for Monitoring Ebolavirus in Wild Great Apes</h3>
<p style="text-align: justify; text-justify: inter-word;">Conclusions/Significance: Our new approach will contribute to a strategy to protect apes from future EBOV infections by early detection of increased incidence of exposure, by identifying immunologically na√Øve at-risk populations as potential targets for vaccination, and by providing a means to track vaccine efficacy if such intervention is deemed appropriate. Finally, since human EVD is linked to contact with infected wildlife carcasses, efforts aimed at identifying great ape outbreaks could have a profound impact on public health in local communities, where EBOV causes case-fatality rates of up to 88%.</p>
<p align="right"><i>score: 37</i></p>

</div><br /><br /><br /><div class="card"><h3>Getting to zero quickly in the 2019-nCov epidemic with vaccines or rapid testing</h3>
<p style="text-align: justify; text-justify: inter-word;">Any plan for stopping the ongoing 2019-nCov epidemic must be based on a quantitative understanding of the proportion of the at-risk population that needs to be protected by effective control measures in order for transmission to decline sufficiently and quickly enough for the epidemic to end. Using an SEIR-type transmission model, we contrasted two alternate strategies by modeling the proportion of the population that needs to be protected from infection by onetime vaccination (assuming 100% effectiveness) or by testing with isolation and treatment of individuals within six, 24, or 48 hours of symptom onset. If R is currently 2.2, vaccination at the herd immunity coverage of 55% would drive R just below 1, but transmission could persist for years. Over 80% of coverage is required to end the epidemic in 6 months with population-wide vaccination. The epidemic could be ended in just under a year if testing with isolation and treatment reached 80% of symptomatically infected patients within 24 hours of symptom onset (assuming 10% asymptomatic transmission). The epidemic could be ended in six months if testing with isolation and treatment reached 90% of symptomatic patients. If 90% of symptomatic patients could be tested within six hours of symptoms appearing, the epidemic could be ended in under four months.</p>
<p align="right"><i>score: 37</i></p>

</div><br /><br /><br /><div class="card"><h3>What Have We Learned About Middle East Respiratory Syndrome Coronavirus Emergence in Humans? A Systematic Literature Review</h3>
<p style="text-align: justify; text-justify: inter-word;">Conclusions: There has been substantial MERS-CoV research since 2012, but significant knowledge gaps persist, especially in epidemiology and natural history of the infection. There have been few rigorous studies of baseline prevalence, transmission, and spectrum of disease. Terms such as ''camel exposure'' and the epidemiological relationships of cases should be clearly defined and standardized. We strongly recommend a shared and accessible registry or database. Coronaviruses will likely continue to emerge, arguing for a unified ''One Health'' approach.</p>
<p align="right"><i>score: 36</i></p>

</div><br /><br /><br /><div class="card"><h3>The incubation period of 2019-nCoV from publicly reported confirmed cases: estimation and application</h3>
<p style="text-align: justify; text-justify: inter-word;">A novel human coronavirus (2019-nCoV) was identified in China in December, 2019. There is limited support for many of its key epidemiologic features, including the incubation period, which has important implications for surveillance and control activities. Here, we use data from public reports of 101 confirmed cases in 38 provinces, regions, and countries outside of Wuhan (Hubei province, China) with identifiable exposure windows and known dates of symptom onset to estimate the incubation period of 2019-nCoV. We estimate the median incubation period of 2019-nCoV to be 5.2 days (95% CI: 4.4, 6.0), and 97.5% of those who develop symptoms will do so within 10.5 days (95% CI: 7.3, 15.3) of infection. These estimates imply that, under conservative assumptions, 64 out of every 10,000 cases will develop symptoms after 14 days of active monitoring or quarantine. Whether this risk is acceptable depends on the underlying risk of infection and consequences of missed cases. The estimates presented here can be used to inform policy in multiple contexts based on these judgments.</p>
<p align="right"><i>score: 36</i></p>

</div><br /><br /><br /><div class="card"><h3>Clinical Medicine Editorial Initial Cluster of Novel Coronavirus (2019-nCoV) Infections in Wuhan, China Is Consistent with Substantial Human-to-Human Transmission</h3>
<p style="text-align: justify; text-justify: inter-word;">Reanalysis of the epidemic curve from the initial cluster of cases with novel coronavirus (2019-nCoV) in December 2019 indicates substantial human-to-human transmission. It is possible that the common exposure history at a seafood market in Wuhan originated from the human-to-human transmission events within the market, and the early, strong emphasis that market exposure indicated animal-to-human transmission was potentially the result of observer bias. To support the hypothesis of zoonotic origin of 2019-nCoV stemming from the Huanan seafood market, the index case should have had exposure history related to the market and the virus should have been identified from animals sold at the market. As these requirements remain unmet, zoonotic spillover at the market must not be overemphasized.</p>
<p align="right"><i>score: 36</i></p>

</div><br /><br /><br /><div class="card"><h3>Tracking progress towards malaria elimination in China: estimates of 1 reproduction numbers and their spatiotemporal variation 2 3</h3>
<p style="text-align: justify; text-justify: inter-word;">we jointly estimate the case reproduction number, , and the number of unobserved sources of 14 infection. We use these estimates within spatio-temporal geostatistical models to map how 15 transmission varied over time and space, estimate the timeline to elimination and the risk of 16 resurgence. Our estimates suggest that, maintaining current intervention efforts, Yunnan is unlikely 17 to experience sustained local transmission up to 2020. However, even with a mean of 0.005 18 projected for the year 2019, locally-acquired cases are possible due to high levels of importation.</p>
<p align="right"><i>score: 36</i></p>

</div><br /><br /><br /><div class="card"><h3>(no title)</h3>
<p style="text-align: justify; text-justify: inter-word;">Here we use previously validated phenomenological models to generate short-term forecasts of cumulative reported cases in Guangdong and Zhejiang, China. Using daily reported cumulative case data up until 13 February 2020 from the National Health Commission of China, we report 5and 10-day ahead forecasts of cumulative case reports. Specifically, we generate forecasts using a generalized logistic growth model, the Richards growth model, and a sub-epidemic wave model, which have each been previously used to forecast outbreaks due to different infectious diseases. Forecasts from each of the models suggest the outbreaks may be nearing extinction in both Guangdong and Zhejiang; however, the sub-epidemic model predictions also include the potential for further sustained transmission, particularly in Zhejiang. Our 10-day forecasts across the three models predict an additional 65-81 cases (upper bounds: 169-507) in Guangdong and an additional 44-354 (upper bounds: 141-875) cases in Zhejiang by February 23, 2020. In the best-case scenario, current data suggest that transmission in both provinces is slowing down.</p>
<p align="right"><i>score: 35</i></p>

</div><br /><br /><br /><div class="card"><h3>Ministry of Health, Directorate of Primary Health Care Development</h3>
<p style="text-align: justify; text-justify: inter-word;">As of February 25, 2019, 875 cases of Ebola virus disease (EVD) were reported in North Kivu and Ituri Provinces, Democratic Republic of Congo. Since the beginning of October 2018, the outbreak has largely shifted into regions in which active armed conflict has been reported, and in which EVD cases and their contacts have been difficult for health workers to reach. We used an ensemble of models to estimate EVD transmission rates and to forecast the short-and long-term course of the outbreak. Our models project that a final size of roughly up to 300 additional cases is most likely, and estimate that transmission rates are higher than would be seen under optimal levels of contact tracing and vaccination. While a catastrophic outbreak is not projected, is it not ruled out, and prevention and vigilance are warranted. Fig 2. Prospective validation of probabilistic projections of auto-regression and stochastic models, by comparing projected cumulative case counts from past data to known case counts. Vertical bars indicate known case counts (height not to scale).</p>
<p align="right"><i>score: 35</i></p>

</div><br /><br /><br /><div class="card"><h3>The timing of one-shot interventions for epidemic control</h3>
<p style="text-align: justify; text-justify: inter-word;">The apparent early success in China's large-scale intervention to control the COVID-19 epidemic has led to interest in whether other countries can replicate it as well as concerns about a resurgence of the epidemic if or when China relaxes the interventions. In this paper we look at the impact of a single short-term intervention on an epidemic. We see that if an intervention cannot be sustained long-term, it has the greatest impact if it is imposed once infection levels have become large enough that there is an appreciable number of infections present. For minimising the total number infected it should start close to the peak so that there is no rebound once the intervention is stopped, while to minimise the peak prevalence, it should start earlier, allowing two peaks of comparable size rather than one very large peak. In populations with distinct subgroups, synchronized interventions are less effective than targeting the interventions in each sub-population separately.</p>
<p align="right"><i>score: 34</i></p>

</div><br /><br /><br /><div class="card"><h3>Stochastic discrete epidemic modeling of COVID-19 transmission in the Province of Shaanxi incorporating public health intervention and case importation</h3>
<p style="text-align: justify; text-justify: inter-word;">Before the lock-down of Wuhan/Hubei/China, on January 23 rd 2020, a large number of individuals infected by COVID-19 moved from the epicenter Wuhan and the Hubei province due to the Spring Festival, resulting in an epidemic in the other provinces including the Shaanxi province. The epidemic scale in Shaanxi was comparatively small and with half of cases being imported from the epicenter. Based on the complete epidemic data including the symptom onset time and transmission chains, we calculate the control reproduction number (1.48-1.69) in Xi'an. We could also compute the time transition, for each imported or local case, from the latent, to infected, to hospitalized compartment, as well as the effective reproduction number. This calculation enables us to revise our early deterministic transmission model to a stochastic discrete epidemic model with case importation and parameterize it. Our model-based analyses reveal that the newly generated infections decay to zero quickly; the cumulative number of case-driven quarantined individuals via contact tracing stabilize at a manageable level, indicating that the intervention strategies implemented in the Shaanxi province have been effective. Risk analyses, important for the consideration of "resumption of work", show that a large second outbreak is expected if the level of case importation remains at the same level as between January 10 th and February 4 th 2020. However, if the case importation decreases by 30%, 60% and 90%, the second outbreak if happening will be of small-scale assuming contact tracing and quarantine/isolation remain as effective as before. Finally, we consider the effects of intermittent inflow with a Poisson distribution on the likelihood of multiple outbreaks. We believe the developed methodology and stochastic model provide an important model framework for the evaluation of revising travel restriction rules in the consideration of resuming social-economic activities while managing the disease control with potential case importation.</p>
<p align="right"><i>score: 34</i></p>

</div><br /><br /><br /><div class="card"><h3>Epidemiology and Transmission of COVID-19 in Shenzhen China: Analysis of 391 cases and 1,286 of their close contacts</h3>
<p style="text-align: justify; text-justify: inter-word;">Rapid spread of SARS-CoV-2 in Wuhan prompted heightened surveillance in Shenzhen and elsewhere in China. The resulting data provide a rare opportunity to measure key metrics of disease course, transmission, and the impact of control.</p>
<p align="right"><i>score: 33</i></p>

</div><br /><br /><br /></body>